Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -111.81% is 50% above its 5-year average of -223.66%, near the high end of its 5-year range (-890.58%–-7.91%).
As of the fiscal period ended Tuesday, June 30, 2026. 146.48% below its 12-month average of -45.36%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -111.81%.
RETURN ON EQUITY (ROE)
-111.81%
RETURN ON EQUITY (ROE) AVG TTM
-45.36%
RETURN ON EQUITY (ROE) AVG 3Y
-33.94%
RETURN ON EQUITY (ROE) AVG 5Y
-223.66%
RETURN ON EQUITY (ROE) AVG 10Y
-302.01%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-146.48%
CURRENT VS 3Y AVG
-229.41%
CURRENT VS 5Y AVG
+50.01%
CURRENT VS 10Y AVG
+62.98%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.89%
median of 684 covered companies
CURRENT VS SECTOR MEDIAN
-173.43%
vs the sector median at left
GridAI Technologies Corp.
Market Cap
$29.95M
Return on Equity (ROE)
-111.81%
TTM Avg
-45.36%
3Y Avg
-33.94%
5Y Avg
-223.66%
Market Cap
$30.00M
Return on Equity (ROE)
-132.18%
TTM Avg
-94.77%
3Y Avg
-38.62%
5Y Avg
-46.78%
Market Cap
$29.65M
Return on Equity (ROE)
N/A
TTM Avg
29.33%
3Y Avg
173.42%
5Y Avg
64.03%
Market Cap
$30.56M
Return on Equity (ROE)
-15.29%
TTM Avg
-28.05%
3Y Avg
-476.74%
5Y Avg
-371.52%
Market Cap
$29.54M
Return on Equity (ROE)
-120.40%
TTM Avg
-43.89%
3Y Avg
-83.08%
5Y Avg
-65.54%
Market Cap
$30.69M
Return on Equity (ROE)
-116.14%
TTM Avg
-228.74%
3Y Avg
113.10%
5Y Avg
76.03%
Market Cap
$29.37M
Return on Equity (ROE)
-117.69%
TTM Avg
-1443.79%
3Y Avg
-971.02%
5Y Avg
-813.57%
Market Cap
$29.16M
Return on Equity (ROE)
N/A
TTM Avg
78.98%
3Y Avg
134.04%
5Y Avg
114.40%
Market Cap
$31.12M
Return on Equity (ROE)
N/A
TTM Avg
10.32%
3Y Avg
-262.53%
5Y Avg
-267.00%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GridAI Technologies Corp. (GRDX) | $29.95M | -111.81% | -45.36% | -33.94% | -223.66% |
| CervoMed Inc. (CRVO)vs › | $30.00M | -132.18% | -94.77% | -38.62% | -46.78% |
| BeyondSpring Inc. (BYSI)vs › | $29.65M | N/A | 29.33% | 173.42% | 64.03% |
| SCYNEXIS, Inc. (SCYX)vs › | $30.56M | -15.29% | -28.05% | -476.74% | -371.52% |
| Context Therapeutics Inc. (CNTX)vs › | $29.54M | -120.40% | -43.89% | -83.08% | -65.54% |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $30.69M | -116.14% | -228.74% | 113.10% | 76.03% |
| Quantum Cyber N.V. (QUCY)vs › | $29.37M | -117.69% | -1443.79% | -971.02% | -813.57% |
| OneMedNet Corporation (ONMD)vs › | $29.16M | N/A | 78.98% | 134.04% | 114.40% |
| MDxHealth S.A. (MDXH)vs › | $31.12M | N/A | 10.32% | -262.53% | -267.00% |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | 2.91% | -2.27% | 5.52% | 6.87% |
ROE
-111.8%
ROA
-49.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -111.81% |
| 2026-03-31 | -38.64% |
| 2025-12-31 | -26.96% |
| 2025-09-30 | -18.57% |
| 2025-06-30 | -30.83% |
| 2025-03-31 | -44.08% |
| 2024-12-31 | -31.24% |
| 2024-09-30 | -14.16% |
| 2024-06-30 | -15.22% |
| 2024-03-31 | -7.91% |
| 2023-12-31 | -438.39% |
| 2023-09-30 | -478.22% |
| 2023-06-30 | -890.58% |
| 2023-03-31 | -334.49% |
| 2022-12-31 | -533.51% |
| 2021-06-30 | -563.87% |
| 2021-03-31 | -243.69% |
| 2020-09-30 | -117.69% |
| 2020-03-31 | -518.83% |
| 2019-12-31 | -328.72% |
| 2019-09-30 | -559.56% |
| 2019-06-30 | -552.73% |
| 2019-03-31 | -536.66% |
| 2018-12-31 | -302.50% |
| 2018-09-30 | -216.81% |
| 2018-06-30 | -164.62% |
| 2017-12-31 | -668.22% |
| 2017-09-30 | -509.65% |
| 2017-06-30 | -308.12% |
| 2016-12-31 | -454.14% |
| 2014-12-31 | -0.09% |
